Clinical Trials

Trial to Assess Chelation Therapy 2

tact-2-logo

 

 

 

 

 

We were a study site for the original Trial to Assess Chelation Therapy (TACT) in which patients with prior heart disease were given a series of  IV chelation treatments designed to bind and eliminate heavy metals from the body.  The results were so impressive, particularly in the diabetic subpopulation, that a second study called TACT2 is now underway.

We are now recruiting patients for TACT2.  To qualify you must be over age 50 and have evidence of heart disease and diabetes.  Again, a series of 40 IV chelation treatments or placebo will be given.  If you think you qualify and are interested in participating please call our office for more information.

TACT results

TACT2 protocol

TACT2 in the News